Task: Answer the multiple choice question.
Query: Which drug exhibits a 1.482\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
(a) CCN(CC)C(=O)CSc1nc2ccccc2c(=O)n1CCC(=O)NCCc1ccc(OC)c(OC)c1
(b) COc1cc(C(=O)Oc2ccccc2/C=N/NC(=O)c2ccc(Cl)cc2Cl)cc(OC)c1OC
(c) C=CCn1c(=NC(=O)c2cc(-c3cccs3)nc3ccccc23)sc2cc(S(N)(=O)=O)ccc21
(d) CCOC(=O)c1cnc2c(C)cc(Cl)cc2c1N1CCN(C)CC1.Cl
(e) Cn1c(SCC(=O)N2CCCC2)nnc1-c1cnccn1
Answer: e. Cn1c(SCC(=O)N2CCCC2)nnc1-c1cnccn1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1c(SCC(=O)N2CCCC2)nnc1-c1cnccn1
Cn1c(SCC(=O)N2CCCC2)nnc1-c1cnccn1
2-[(4-methyl-5-pyrazin-2-yl-1,2,4-triazol-3-yl)sulfanyl]-1-pyrrolidin-1-ylethanone